Ro key facts
- Operator of a direct-to-consumer telehealth platform intended to handle everything from diagnosis to convenient medication delivery.
- It has raised $1.1B; the latest was Debt - General ($30.0M) in Jul 2024.
- Notable investors include Plug and Play Tech Center, General Catalyst, Insight Partners (New York), Gaingels, BoxGroup — 50 tracked in total.
- Status: Privately Held (backing).
Who backs Ro
50+- ·The complete investor list: 50 names
- ·Watch Ro: the Monday email on marks, rounds and moves
Ro funding rounds
No funding rounds for Ro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ro investors
50 investors are on record for Ro, including Plug and Play Tech Center, General Catalyst, Insight Partners (New York) and Gaingels. By type, the record holds 16 venture capital firms and 3 asset managers.
About Ro
Operator of a direct-to-consumer telehealth platform intended to handle everything from diagnosis to convenient medication delivery. The company's platform allows people to get in touch with physicians and has end-to-end services, some for erectile dysfunction and others to help people quit smoking, enabling users to get access to free medication delivery and personalized treatment.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 831
- Website
- ro.co/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Ro doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.